NeuroTalk Support Groups - Leading Emory Psychiatrist ‘Fails’ to Report $1.2 Million of Drug Income

Emory University psychiatrist Charles Nemeroff has been accused of not reporting almost half of the $2.8 million he had received from drug company GlaxoSmithKline between 2000 and 2007 as payment for heading a National Institutes of Health study on five anti-depressants produced by the company. By doing so, he has violated federal research rules.

The man pointing the finger is Senator Charles E. Grassley, who addressed an open letter to Emory University on Friday by publishing it in the Congressional Record. Grassley, an advocate of transparency in medical payments is promoting a bill titled the Physician Payment Sunshine Act, which if passed, will require drug companies and medical device manufacturers to disclose any payments over a certain value that they make to physicians. Two companies, Eli Lilly & Co. and Merck & Co, have said that they will make such disclosures starting next year, even if the bill is not passed.

http://www.efluxmedia.com/news_Leadi...ome_25806.html